News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study     9/2/2014
Novo Nordisk A/S (NVO) Drops Inflammatory Disorder Business; 400 Staffers Impacted     9/2/2014
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales     9/2/2014
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk     9/2/2014
Belgium Biotech ThromboGenics NV (TBGNF) Cuts Around A Fifth Of Employees     9/2/2014
Resverlogix Corporation (RVX.TO)'s RVX-208 Leads To A 77 Percent Relative Risk Reduction Of Major Heart Events     9/2/2014
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™     9/2/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab     9/2/2014
Bayer HealthCare (BAY) Starts Its Own Accelerator     9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent     9/2/2014
Baxter International, Inc. (BAX)'s Hunt For Space In Cambridge Triggers A Counter Effort In Illinois     9/2/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Cholesterol-Lowering Medication Evolocumab     9/2/2014
Amgen (AMGN) Submits Marketing Authorization Application For Talimogene Laherparepvec     9/2/2014
Clearside Biomedical Snags $16 Million Series B Financing     9/2/2014

Featured Stories
"Back To Normal" For AstraZeneca PLC (AZN) CEO, Despite Pfizer Inc. (PFE) Rumors     9/2/2014
Wine Only Protects The Heart When You Exercise, Palacky University Study     9/2/2014
Drinking Tea, Not Coffee, Could Help You Live Longer, European Society of Cardiology Reveals     9/2/2014
How Plants In The Office Make Workers More Productive, University of Exeter Study     9/2/2014
Dieting? Low-Carb Trumps Low-Fat For Weight Loss, Heart Health, Tulane University Study     9/2/2014
Energy Drinks Cause Heart Problems, European Society of Cardiology Reveals     9/2/2014
Coffee And Nap Can Increase Alertness, Loughborough University Study     9/2/2014
Boy Born Without A Brain Dies At Age 12     9/2/2014
Chinese Farmer Whose Head Was Crushed Will Be Fitted With 3D-Printed Skull, Xijing Hospital Reveals     9/2/2014
Short Men Make Better Boyfriends And Husbands, New York University Study     8/29/2014
Less Sleep In Teen Years Tied To More Pounds At 21, Columbia University Study     8/29/2014
Centers for Disease Control and Prevention (CDC): There's More Trans Fat Lurking In U.S. Foods Than You Think     8/29/2014
Married Couples Who Smoke Pot Are Happier? University at Buffalo Study     8/29/2014
Certain Toothbrushes Hold 3,000 Times More Germs, University of Texas Health Science Center Researchers Reveal     8/29/2014
Marijuana Compound Could Stop Or Slow Down Alzheimer’s, University of South Florida Study     8/29/2014

More News
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema     9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures     9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease     9/2/2014
Salix Pharmaceuticals, Ltd. (SLXP) Submits Response To XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment For Irritable Bowel Syndrome With Diarrhea     9/2/2014
Ipsen (IPN.PA) Announces Acceptance Of Filings For Somatuline® In The Treatment Of GEP-NET1s In The U.S. With Priority Review And In Europe     9/2/2014
Prosonix' Marketing Authorisation Application For PSX1001 - A Generic Version Of GlaxoSmithKline (GSK)'s Flixotide® Evohaler® - Under Assessment In EU     9/2/2014
Actavis (ACT) Announces FDA Acceptance For Filing Of NDA For Eluxadoline     9/2/2014
Hatchtech Announces Successful Phase 3 Study Results For Xeglyze™ Lotion     9/2/2014
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers     9/2/2014
Sophiris Bio Inc. (SPHS) Reports Completion Of Enrollment In The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia     9/2/2014
Teva Pharmaceutical Industries Limited (TEVA)’s Reslizumab Delivers Clinically And Statistically Significant Reduction In Asthma Exacerbations In Two Pivotal Phase 3 Studies     9/2/2014
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee     9/2/2014
Birken Announces Positive Results Of Phase 3 Trials With Oleogel-S10 For Accelerated Wound Healing In Patients With Partial Thickness Wounds     9/2/2014
Conatus Pharmaceuticals Inc. Initiates Phase 2 Trial In Patients With Liver Cirrhosis And Separate Open Label Phase 2 Trial In Cirrhosis Patients With Portal Hypertension     9/2/2014
Alcobra (ADHD) Announces Enrollment Of First Patient In Phase 2b Clinical Trial Of MDX In Adolescents With ADHD     9/2/2014
Cellular Biomedicine Group (CBMG) Launches Clinical Research Study For Cartilage Defect Stem Cell Therapy     9/2/2014
Nuvilex (NVLX) Submits Application For Orphan Drug Designation To The European Medicines Agency For Its Cell-In-A-Box® Treatment For Pancreatic Cancer     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For The Treatment Of Myelofibrosis     9/2/2014
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Completes Enrollment In Randomized Phase 2 Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome     9/2/2014
VentiRx Pharmaceuticals, Inc. Announces Fast Track Designation Granted For Motolimod (VTX-2337), A Novel Immunotherapy For Women With Ovarian Cancer     9/2/2014
Xention Limited Commences First Phase 2 Study Of XEN-D0103 In Atrial Fibrillation     9/2/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Initiates Phase 1(B) Safety And Tolerance Study For CPP-115     9/2/2014
Capstone Therapeutics (CAPS) Announces Phase 1a Results For AEM-28 Showing Safety And Biomarker Efficacy Signals     9/2/2014
Boston Strategics Corporation Initiates A Phase 1 Clinical Trial Of The Anti-Cancer Agent "FF-10501" For FUJIFILM In Patients With Advanced Hematologic Malignancies     9/2/2014
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announces Commencement Of A Phase 1 Single Ascending Dose Study Of A Novel Antifungal Agent, F901318.     9/2/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure     9/2/2014
Zogenix, Inc. (ZGNX) Release: Zohydro® ER Demonstrates Sustained 12-Hour Pain Relief     9/2/2014
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin     9/2/2014
Imperial College London To Present First Public HBV Data From CN Bio Innovations In Vitro Liver Model     9/2/2014
Galleon Pharmaceuticals, Inc. Announces Publication Of Proof-Of-Concept Clinical Studies For GAL-021, Projected Use For The Emerging Perioperative Sleep Apnea Epidemic     9/2/2014
SAGE Therapeutics Presents New Preclinical Data On SAGE-217 At Eilat Conference On New Anti-Epileptic Drugs     9/2/2014
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For Fhe Treatment Of Myelofibrosis     9/2/2014
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment     9/2/2014
Bayer HealthCare (BAY) Release: New Data Show Once-Daily XARELTO® May Be An Alternative To Vitamin K Antagonists In Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion     9/2/2014
Daiichi Sankyo, Inc. (4568.t) Release: One Year Data From The PREFER In AF Registry Show Significant Changes In Atrial Fibrillation (AF) Management In Europe And Implementation Of Clinical Guidelines     9/2/2014
TransCelerate BioPharma Releases Recommended Approach For Protecting Personal Data In Clinical Study Reports     9/2/2014
Exco Intouch Achieve A New First In Mobile Clinical Technology     9/2/2014
Tufts University Release: War Between Bacteria And Phages Benefits Humans     9/2/2014
BioLegend Acquires The Antibody Products Business Unit From Covance Inc. (CVD)     9/2/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China     9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories     9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox     9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements     9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis     9/2/2014
Intrexon Corporation Announces Exclusive Channel Collaboration With Sanofi (France) (SAN.PA) To Optimize Production For A Specific Family Of Active Pharmaceutical Ingredients     9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products     9/2/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension     9/2/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX)     9/2/2014
Marinus Pharmaceuticals (MRNS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock     9/2/2014
Agile Therapeutics, Inc. To Ring The NASDAQ Stock Market Closing Bell     9/2/2014
Aurinia (ISA.TO) To Begin Trading On The NASDAQ Global Market     9/2/2014
Creative BioMart Session---Summary Of August Promotion     9/2/2014
TAP Biosystems Release; Major Pharma Chooses CompacT SelecT Automated Cell Culture SystemTo Generate Consistent, High Quality Cell Plates For Transport Assays     9/2/2014
Cellectis (ALCLS): Genome Engineering & CART Cells: At The Forefront Of Immuno-Oncology     9/2/2014
Lorus Therapeutics Inc. (LRP) Implements Name Change To Aptose Biosciences     9/2/2014
Nordic Nanovector – Subsequent Offering     9/2/2014
VentiRx Pharmaceuticals, Inc. Provides Corporate And Clinical Update     9/2/2014
Agilent Technologies Inc. (A) Introduces Next-Generation Sequencing Cancer Research Panels     9/2/2014
Stellar Biotechnologies, Inc. Reports On Unusual Trading Activity     9/2/2014
Daxor Corporation (DXR) Announces Filing Of Form N-CSR For June 30, 2014     9/2/2014
Allergan Inc. (AGN) Files Answer In Federal Court Responding To Valeant Pharmaceuticals International (VRX) And Pershing Square’s Counterclaims     9/2/2014
U.S. FDA Grants QIDP Status For Wockhardt (WOCKHARDT.BO) Anti-Infective Drug Discovery Program     9/2/2014
DS Healthcare Group To Open Its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies For Hair Loss     9/2/2014
Source BioScience Launches Intelligent GenomeCUBE Search Engine     9/2/2014
Agilent Technologies Inc. (A) Introduces Higher-Performance Q-TOF GC/MS System, Featuring Optimized Hardware/Software Capabilities     9/2/2014
BIOCRATES Life Sciences GmbH Announces Launch Of First-ever Standardized Metabolomics-based Bile Acids Kit     9/2/2014
ERYtech Pharma Business Update And Financial Results For The First Half Of 2014     9/2/2014
Pfenex Inc. (PFNX) Reports Second Quarter 2014 Results And Provides Business Update     9/2/2014
uniQure Announces Results For The Second Quarter And First Half Of 2014 And Provides Update On Gene Therapy Programs     9/2/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation     9/2/2014
Tokai Pharmaceuticals Appoints Lee Kalowski As Chief Financial Officer     9/2/2014
Mast Therapeutics (MSTX) Announces Management Change     9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group     9/2/2014
EMD Group (EMD Serono, Inc. (Rockland)) Appoints Drew Young To Senior Vice President, Neurology And Immunology     9/2/2014
Aldeyra Therapeutics (ALDX) Expands Drug Development Team In Advance Of NS2 Clinical Trials     9/2/2014
Distinguished Scientists Join Advanced Cell Technology’s New Scientific Advisory Board     9/2/2014
Cellceutix (CTIX) Appoints Dr. Barry Schechter To Board Of Directors As Company Focuses On Meeting Requirements For Stock Exchange Uplisting     9/2/2014
Aesica Celebrates 10th Anniversary As Eight Fold Increase In Sales Accompanies Successful Transition Into An International Full Service CDMO     9/2/2014
Contract Research Organization WCCT Global Celebrates Being Named As One Of The Fastest Growing Companies In America     9/2/2014
XYMOGEN Ranked Among The Nation's Fastest Growing Private Companies For A Seventh Time     9/2/2014
Linguamatics Ltd I2E Semantic Enrichment Named As A KMworld 2014 Trend-Setting Product     9/2/2014
MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The 18th International Colloquium On Lung And Airway Fibrosis (ICLAF)     9/2/2014
Vectura Group plc (VEC.L) Release: Presentations At ERS     9/2/2014
Dipexium Pharmaceuticals (DPRX) Announces Presentation At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
Imperial College London To Present First Public HBV Data From CN Biosciences (CNBI) In Vitro Liver Model     9/2/2014
NephroGenex (NRX) To Participate In Four Healthcare Conferences In September     9/2/2014
Merck & Co., Inc. (MRK) To Present New Data In Five Tumor Types From Studies Evaluating Pembrolizumab, The Company’s Investigational Anti-PD-1 Antibody, At ESMO 2014     9/2/2014
Abaxis, Inc. (ABAX) To Present At CL King's 12th Annual Best Ideas Conference 2014     9/2/2014
Opexa Therapeutics (OPXA) To Present At September Conferences     9/2/2014
Sinovac Biotech Ltd. (SVA) To Participate In Upcoming Investor Conferences     9/2/2014
Bristol-Myers Squibb Company (BMY) Release: Secondary Analysis Of AMPLIFY-EXT Examining Predictors Of Hospitalization Presented At ESC Congress: Eliquis (Apixaban) Significantly Reduced The Risk Of All-Cause Hospitalization Versus Placebo In Patients With Venous Thromboembolism (VTE)     9/2/2014
Agenus (AGEN) To Participate In Two Upcoming Investor Conferences     9/2/2014
Teleflex Incorporated (TFX) To Present For The First Time At The 32nd Annual World Congress Of Endourology And Shockwave Lithotripsy     9/2/2014
OncoSec Medical Inc. To Present At Five Events In September     9/2/2014
CytRx Corporation (CYTR) To Present At Upcoming Investor Conferences In New York City And Las Vegas     9/2/2014
Delenex Therapeutics Release: New Clinical Data On The Topical Application Of PENTRA®Bodies To Be Presented At The 44th Annual ESDR Meeting     9/2/2014
Portola Pharmaceuticals, Inc. To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Versartis, Inc. (VSAR) To Present At The Morgan Stanley (MST) 2014 Global Healthcare Conference     9/2/2014
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
XenoPort, Inc. (XNPT) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Bristol-Myers Squibb Company (BMY) To Take Part In Morgan Stanley (MST) Global Health Care Conference     9/2/2014
Seattle Genetics, Inc. (SGEN) To Present At Morgan Stanley (MST) Healthcare Conference     9/2/2014
Thermo Fisher Scientific (TMO) To Present At The Morgan Stanley (MST) Global Healthcare Conference On September 9, 2014     9/2/2014
Waters Corporation (WAT) Commentary At The Morgan Stanley (MST) Global Healthcare Conference To Be Audio Webcast Live     9/2/2014
Synageva BioPharma (GEVA) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
AVANIR Pharmaceuticals (AVNR) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Spectrum Pharmaceuticals, Inc. (SPPI) To Present Corporate Update At The Morgan Stanley (MST) Global Healthcare Conference In New York City On September 9th     9/2/2014
Ophthotech Corporation (OPHT) To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Acorda Therapeutics (ACOR) To Present At The Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Fluidigm Corporation To Present At Morgan Stanley (MST) Global Healthcare Conference     9/2/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At 16th Rodman & Renshaw Annual Global Investment Conference     9/2/2014
Celator Pharmaceuticals, Inc. To Present At Rodman & Renshaw 16th Annual Global Investment Conference     9/2/2014
BioLineRx Ltd. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York     9/2/2014
Biocryst Pharmaceuticals (BCRX) To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting     9/2/2014
Dicerna Pharmaceuticals (DRNA) To Present At The Baird 2014 Health Care Conference     9/2/2014

Career Tips
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story     8/8/2014
Allergan Inc. (AGN) Layoffs Mean Resume-Tweaking Time: Tips For Creating An Exceptional Resume     8/7/2014
Top Exec Reveals 5 Habits That May Advance Your Career     8/7/2014
11 Hard To Believe Job Search Blunders     8/7/2014
How To Adopt A Recruiter's Mindset When Writing Your Resume     8/7/2014
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     8/7/2014
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news